StemGenex™, adipose-derived stem cells for diabetes

StemGenex™ is comprised of adipose-derived stem cells that are acquired by a mini-liposuction and processed with platelet-rich plasma (PRP), which includes growth factors that have a powerful impact on cell development, growth and proliferation. A specialized low-laser light is used to activate both the platelets of the PRP and the stem cells. The activated mixture is then administered via an intravenous infusion over a 1-2 hour period to treat diabetes.